Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi expert panel recommendations from ITSCC
DermatologiaSobre o estudo
- Desenho
- Diretriz clínica
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Journal of the American Academy of Dermatology
- Publicado em
- 31 mar 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Topical combined 5-fluorouracil and calcipotriene for actinic keratosis and superficial keratinocyte carcinoma: Modified Delphi expert panel recommendations from ITSCC
Nicole Loranger, Nicole Trepanowski, Payal Shah, Leora Aizman, Jennifer DeSimone, Stephanie Jackson Cullison, Fatemeh Jafarian, Kimberly M Ken, Mary E Lohman, Jennifer S Ranario et al.
Descritores MeSH
- Basal Cell Carcinoma
- Skin Neoplasms
- Keratosis, Actinic
- Carcinoma, Squamous Cell
- Calcitriol
- Fluorouracil
- Delphi Technique
- Cutaneous Squamous Cell Carcinoma
- Humans
Veja também
Estudos relacionados
- Chemoprevention of keratinocyte carcinomas and actinic keratoses in adults who were immunocompetent: a systematic review
- Histological and Genetic Markers of Cellular Senescence in Keratinocyte Cancers and Actinic Keratosis: A Systematic Review
- Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review
- Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review